Document:

Document

Exhibit 10.5

Summary of Terms of the Annual Restricted Stock Unit Grants for the Non-Associate Directors of Abercrombie & Fitch Co. under the Abercrombie & Fitch Co. 2016 Long-Term Incentive Plan for Directors in Fiscal 2021

Non-Associate Directors

For the fiscal year ending January 29, 2022 (“Fiscal 2021”), members of the Board of Directors (the “Board”) of Abercrombie & Fitch Co. (the “Company”) who are not employees, or as referred to by the Company, “associates”, of the Company or of a subsidiary of the Company (“non-associate directors”) are eligible to receive an annual grant of restricted stock units (“RSUs”) as part of their compensation. Each RSU represents the right to receive one share of Class A Common Stock, $0.01 par value, of the Company (the “Common Stock”), upon vesting. The market value of the shares of Common Stock underlying the RSUs on the grant date is to be $150,000 (the “Non-Associate Director RSU Retainer”).

The annual Non-Associate Director RSU Retainer has been and will continue to be subject to the following provisions:

•RSUs are to be granted annually on the date of the annual meeting of stockholders of the Company (if the non-associate directors continue to serve after the annual meeting of stockholders), which for Fiscal 2021 is the date of the 2021 Annual Meeting of Stockholders held on June 9, 2021, with such grant being made pursuant to the Abercrombie & Fitch Co. 2016 Long-Term Incentive Plan for Directors (or any successor plan approved by the Company’s stockholders).

•RSUs will vest on the earlier of (i) the first anniversary of the grant date or (ii) the date of the next regularly scheduled annual meeting of stockholders of the Company after the grant date, subject to earlier vesting in the event of a non-associate director’s death or total disability or upon termination of service in connection with a change of control of the Company.

Non-Executive Chairman of the Board

In his capacity as the Non-Executive Chairman of the Board of the Company, Terry L. Burman is to receive the following additional equity compensation for Fiscal 2021:

•An additional annual grant of RSUs, with the market value of the shares of Common Stock underlying this annual grant being equal to $100,000 on the grant date (the “Non-Executive Chairman RSU Retainer”), to be granted on the date of the annual meeting of stockholders of the Company (if Mr. Burman continues to serve after the annual meeting of stockholders), which for Fiscal 2021 is the date of the 2021 Annual Meeting of Stockholders held on June 9, 2021,  with such grant being made pursuant to the Abercrombie & Fitch Co. 2016 Long-Term Incentive Plan for Directors (or any successor plan approved by the Company’s stockholders).  These additional RSUs will vest on the earlier of (i) the first anniversary of the grant date or (ii) the date of the next regularly scheduled annual meeting of stockholders of the Company after the grant 

date; in each case, subject to earlier vesting in the event of Mr. Burman’s death or total disability or upon a change of control of the Company.

•if Mr. Burman’s service as Non-Executive Chairman of the Board of the Company ends for any reason other than his death or total disability, a pro-rata portion of unvested RSUs subject to the Non-Executive Chairman RSU Retainer will vest to reflect the portion of the year that has elapsed between the grant date and the date on which his service as Non-Executive Chairman of the Board of the Company ends.Exhibit 10.1
EMPLOYMENT AGREEMENT AMENDMENT NO. 1
This Amendment No. 1 to the EMPLOYMENT AGREEMENT (this “Agreement”) dated as of April 18, 2016, by and between VASCO Data Security International, Inc. (now known as OneSpan Inc.) (the “Company”), and Steven Worth (“Executive”) is dated as of June 9, 2021 (the “Effective Date”).
WHEREAS, the Company desires to continue to employ Executive and Executive desires to be employed by the Company.
NOW, THEREFORE, in consideration of the mutual undertakings of the parties hereto, the Company and Executive agree as follows:
		1.	Section 1.2: A new sentence shall be added as follows “From the Effective Date until the earliest to occur of: the cancellation by the Chief Executive Officer or the termination of the Employment Period or the resignation of the Interim Chief Financial Officer position by Executive, Executive shall have the additional position of Interim Chief Financial Officer.”

		2.	Section 1.4: “Oakbrook Terrace” shall be replaced with “City of Chicago”.

		3.	 Section 2.1: “$325,000” shall be replaced with “$366,011”. A new sentence shall be added as follows “During each month or portion thereof that Executive holds the position of Interim Chief Financial Officer, Executive shall receive an additional fee of $10,000 per month.”

		4.	Section 2.2: A new sentence shall be added as follows “From calendar year 2021, Executive shall be provided a target bonus equal to at least $250,000 for the Annual Bonus Plan.”

		5.	Section 2.3: A new sentence shall be added as follows “From calendar year 2021, Executive shall be provided an award of at least $750,000 under the Long Term Incentive Plan structured in the discretion of the board of directors.”

		6.	Section 3.3: Subsection A pertaining to the definition of Severance Pay shall be replaced as follows:

		a.	Existing subsection A- “an amount equal to six (6) months of Executive’s then current Base Salary, plus an amount equal to 50% of Executive’s target bonus under the Annual Bonus Plan for the current year in which Executive’s employment terminates, or if such target has not been established for such current year, then the most recently established target bonus under the Annual Bonus Plan, each less applicable withholdings, payable in equal installments on each regularly scheduled payroll pay date during the six (6) month period that begins on the first day immediately after the Release Effective Date (as defined in Section 3.7); and”

		b.	New subsection A- “an amount equal to twelve (12) months of Executive’s then current Base Salary, plus an amount equal to 100% of Executive’s target bonus under the Annual Bonus Plan for the current year in which Executive’s employment terminates, or if such target has not been established for such current year, then the most recently established target bonus under the Annual Bonus Plan, each less applicable withholdings, payable in equal installments on 

1

			each regularly scheduled payroll pay date during the twelve (12) month period that begins on the first day immediately after the Release Effective Date (as defined in Section 3.7); and”

		7.	This Agreement may be executed in one or more counterparts, including through electronic signature, each of which shall be considered an original instrument, but all of which shall be considered one and the same agreement. All other terms of the Employment Agreement shall continue to have effect without modification except as specifically provided for herein.

​
IN WITNESS WHEREOF, each of the parties hereto has duly executed this Amendment No. 1 to Employment Agreement.
	​

	​

	​

	​

	​

	​
	ONESPAN INC.

	​
	​
	​

	Date: June 9, 2021
	By:
	/s/ Scott Clements
	​

	​
	​
	​
	​

	​
	Name:
	Scott Clements

	​
	Title:
	President, Chief Executive Officer, and Director

	​
	​
	​

	​
	​
	​

	​
	STEVEN WORTH

	​
	​
	​

	Date: June 9, 2021
	/s/ Steven R. Worth
	​

	​
	​
	​

	​
	​
	​

	​
	​
	​

​

2EX-4.1

 Exhibit 4.1 
  

 
 NUMBER BB LI 
Lyell Lyell Immunopharma, Inc. LYELL
IMMUNOPHARMA, INC. 
SHARES 
CUSIP 097702 10 4 
INCORPORATED UNDER THE LAWS OF THE STATE OF DELAWARE 
SEE REVERSE FOR CERTAIN DEFINITIONS AND
LEGENDS 
This certifies that 
is the record holder of 
FULLY PAID AND NONASSESSABLE SHARES OF COMMON STOCK, $0.00001 PAR VALUE PER SHARE, OF

transferable on the books of the Corporation in person or by duly authorized attorney upon surrender of this Certificate properly endorsed. This Certificate is not
valid until countersigned by the Transfer Agent and registered by the Registrar. 
WITNESS the facsimile seal of the Corporation and the facsimile signatures of its
duly authorized officers. 
Dated: 
CHIEF EXECUTIVE OFFICER 
BOLT BIOTHERAPEUTICS, INC. 
CORPORATE SEAL 
JANUARY 22, 2015 
DELAWARE 
SECRETARY 
COUNTERSIGNED AND REGISTERED: 
AMERICAN STOCK TRANSFER & TRUST COMPANY, LLC 
(BROOKLYN, NY) 
TRANSFER AGENT AND REGISTRAR 
BY: 
AUTHORIZED SIGNATURE 

 The Corporation shall furnish without charge to each stockholder who so requests a statement
of the powers, designations, preferences and relative, participating, optional or other special rights of each class of stock of the Corporation or series thereof and the qualifications, limitations or restrictions of such preferences and/or rights.
Such requests shall be made to the Corporation’s Secretary at the principal office of the Corporation. 
 KEEP THIS CERTIFICATE IN A
SAFE PLACE. IF IT IS LOST, STOLEN,OR DESTROYED THE CORPORATION WILL REQUIRE A BOND INDEMNITY AS A CONDITION TO THE ISSUANCE OF A REPLACEMENT CERTIFICATE. 

The following abbreviations, when used in the inscription on the face of this certificate, shall be construed as though they were written out
in full according to applicable laws or regulations: 
  

																	
	TEN COM	  	–	  	as tenants in common	  		  	UNIF GIFT MIN ACT	 	–	  	                    	  	Custodian	 	                
	TEN ENT	  	–	  	as tenants by the entireties	  		  		 		  	(Cust)	  		 	(Minor)
	JT TEN	  	–	  	as joint tenants with right of	  		  		 		  	under Uniform Gifts to Minors
		  		  	survivorship and not as tenants	  		  		 		  	Act                                   
                   
		  		  	in common	  		  		 		  	(State)
	COM PROP	  	–	  	as community property	  		  	UNIF TRF MIN ACT	 	–	  	             Custodian (until
age              )

		  		  		  		  		 		  	 (Cust)	  		 	
		  		  		  		  		 		  	
                    under Uniform
Transfers

		  		  		  		  		 		  	    (Minor)	 	
		  		  		  		  		 		  	to Minors
Act                                    
		  		  		  		  		 		  	            (State)

 Additional abbreviations may also be used though not in the above list. 

FOR VALUE RECEIVED, _____________________________________________________ hereby sell(s), assign(s) and transfer(s) unto 

PLEASE INSERT SOCIAL SECURITY OR OTHER 

IDENTIFYING NUMBER OF ASSIGNEE 
  

					
	     

 
	  		  	

  

							
	  
 (PLEASE
PRINT OR TYPEWRITE NAME AND ADDRESS, INCLUDING ZIP CODE, OF ASSIGNEE)

  

							
	  

    

 

							
	  

    

 

							
	 	  	shares
	 of the capital stock represented by within Certificate, and do hereby irrevocably
constitute and appoint

  

							
	 	  	 attorney-in-fact

	 to transfer the said stock on the books of the within named Corporation with full
power of the substitution in the premises.

  

					
	 Dated
                                         
                                         
  

  

							
	 	  	X	  	  

	 	  	X	  	  

	Signature(s) Guaranteed:	  		  	Notice:	  	THE SIGNATURE TO THIS ASSIGNMENT MUST CORRESPOND WITH THE NAME AS WRITTEN UPON THE FACE OF THE CERTIFICATE IN EVERY PARTICULAR, WITHOUT ALTERATION OR ENLARGEMENT OR ANY CHANGE WHATSOEVER.

  

	
	
	By
                                         
                                         
                                         
                                         
      
	THE SIGNATURE(S) SHOULD BE GUARANTEED BY AN ELIGIBLE GUARANTOR INSTITUTION, (BANKS, STOCKBROKERS,
SAVINGS AND LOAN ASSOCIATIONS AND CREDIT UNIONS WITH MEMBERSHIP IN AN
APPROVED SIGNATURE
GUARANTEE MEDALLION PROGRAM), PURSUANT TO S.E.C. RULE 17Ad-15. GUARANTEES BY A NOTARY PUBLIC ARE NOT
ACCEPTABLE. SIGNATURE GUARANTEES MUST NOT BE DATED.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00328-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00328-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00328-of-00352.parquet"}]]